DiscoverBreakthroughsMeeting the challenge of Antimicrobial Resistance (AMR)
Meeting the challenge of Antimicrobial Resistance (AMR)

Meeting the challenge of Antimicrobial Resistance (AMR)

Update: 2023-05-102
Share

Description

Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
 

PP-UNP-GBR-11741 / March 2025


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Meeting the challenge of Antimicrobial Resistance (AMR)

Meeting the challenge of Antimicrobial Resistance (AMR)

Pfizer